2005-12-01
One-year outcome of psychotic depression after successful electroconvulsive therapy
Publication
Publication
The Journal of Electroconvulsive Therapy , Volume 21 - Issue 4 p. 221- 226
Background: Psychotic depression is thought to have a higher relapse frequency after electroconvulsive therapy (ECT) compared with nonpsychotic depression, although this observation is contradicted by previous studies that have found the opposite. In this study, the 1-year risk of relapse after successful ECT was determined prospectively in patients with psychotic depression and compared with the risk of relapse observed for depressed patients without psychotic features. Method: Fifty-nine responders to ECT (a decrease in Hamilton Rating Scale for Depression [HAM-D] score ≥ 50%) were followed for 1 year: 29 with and 30 without psychotic features. Relapse was defined as meeting DSM-IV criteria for major depressive disorder and a HAM-D score ≥ 16. The frequency of relapse after 4 and 12 months was compared between both samples, adjusted for the co-variables duration of the index episode and type of post-ECT pharmacotherapy. Results: At both 4 and 12 months after ECT, instances of relapse were significantly lower in patients with psychotic depression compared with nonpsychotic patients: 3/28 (11%) versus 16/27 (59%) and 4/27 (15%) versus 19/28 (68%), respectively. Conclusions: The main finding of the present study is the favorable 1-year outcome for patients with psychotic depression after response to ECT with a trend toward the same result at 4 months. The 1-year outcome of the total sample is also more favorable than expected. Copyright
Additional Metadata | |
---|---|
, , , | |
doi.org/10.1097/01.yct.0000183269.62735.89, hdl.handle.net/1765/67269 | |
The Journal of Electroconvulsive Therapy | |
Organisation | Department of Psychiatry |
Birkenhäger, T.K, van den Broek, W.W, Mulder, P.G.H, & de Lely, A. (2005). One-year outcome of psychotic depression after successful electroconvulsive therapy. The Journal of Electroconvulsive Therapy, 21(4), 221–226. doi:10.1097/01.yct.0000183269.62735.89
|